Biotechnology · Healthcare
Board Member
2026-06-11–present
Equibles does not estimate personal net worth.
Get an email with a short summary when Azora Therapeutics, Inc. (DE) publishes a filing, an earnings call transcript or a press release.
Get AZR alertsMatt Davidson is recorded as Board Member at Azora Therapeutics, Inc. (DE) (AZR) since June 11, 2026. Azora Therapeutics, Inc. (DE) reported in an 8-K filed June 11, 2026 that Matt Davidson was appointed Chief Development Officer, effective June 11, 2026. Azora Therapeutics, Inc. (DE) reported in an 8-K filed June 11, 2026 that Matt Davidson was appointed Class I Director, effective June 11, 2026. Azora Therapeutics, Inc. (DE) is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Azora Therapeutics, Inc. (DE) includes Matthew Davidson (CEO), Matthew Davidson, Ph.D. (CEO), William B. Stilley (CEO) and 7 others.
“Dr. Davidson was also appointed as the Company’s Chief Development Officer.”
“Matt Davidson, Ph.D., was appointed to the Board as a Class I Director, to fill the vacancy created by the resignation of Mr. Goodman, with a term expiring at the Company’s 2028 Annual Meeting of Stockholders”
2026-06-11–present
2026-06-11–present
Biotechnology · Healthcare
Board Member
2026-06-11–present